Home NDC 51662-1220 DOPAMINE HCI
Product NDC 51662-1220
11-digit product format 516621220
Labeler code 51662
Product ID 51662-1220_11ffcdfd-1b2f-90a1-e063-6394a90adede
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DOPAMINE HCI
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler HF Acquisition Co. LLC, DBA Health First
Application NDA018132
Marketing category NDA
Marketing start 2018-08-23
Substance DOPAMINE HYDROCHLORIDE
Active strength 40 mg/mL
Pharmacologic classes Catecholamine [EPC], Catecholamines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018132-001 DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 N018132-002 DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 N018132-003 DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 N018132-004 DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018132-001 DOPAMINE HYDROCHLORIDE 40MG/ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018132-002 DOPAMINE HYDROCHLORIDE 80MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018132-003 DOPAMINE HYDROCHLORIDE 160MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-02-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018132-004 DOPAMINE HYDROCHLORIDE 80MG/ML INJECTABLE / INJECTION AP RLD, RS 1982-07-09 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 176 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base DOPAMINE HCI
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DOPAMINE HYDROCHLORIDE 40 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7L3E358N9L Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1743938 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51662-1220-1 DOPAMINE HCI 10 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION, CONCENTRATE 10 7 51662-1220-2 DOPAMINE HCI 1 in 1 POUCH INJECTION, SOLUTION, CONCENTRATE 1 7 51662-1220-2 DOPAMINE HCI 10 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION, CONCENTRATE 10 7 51662-1220-3 DOPAMINE HCI 25 in 1 CASE INJECTION, SOLUTION, CONCENTRATE 25 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51662-1220 DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE [HF ACQUISITION CO. LLC, DBA HEALTH FIRST] 7 Current NDC, Legacy NDC, 4 package rows 20240224_74205252-3949-57fa-e053-2991aa0aee4d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join DOPamine Hydrochloride DOPAMINE HYDROCHLORIDE Hospira, Inc. 1f306ad2-3606-4525-5a8a-ce78f426c1a2 2026-05-13 Warnings, Adverse reactions Exact identifier application applno (NDA): 018132 application number: NDA018132 DOPamine Hydrochloride DOPAMINE HYDROCHLORIDE ProPharma Distribution 45b0729e-529b-02f6-e063-6294a90a31d3 2025-12-11 Warnings, Adverse reactions Exact identifier application applno (NDA): 018132 application number: NDA018132 DOPAMINE HCI DOPAMINE HCI HF Acquisition Co. LLC, DBA Health First 74205252-3949-57fa-e053-2991aa0aee4d 2024-02-22 Warnings, Adverse reactions Exact identifier application applno (NDA): 018132 application number: NDA018132 ndc (product): 51662-1220 DOPAMINE HCI DOPAMINE HCI HF Acquisition Co LLC, DBA HealthFirst 763d2b07-9cea-782e-e053-2a91aa0adc01 2024-02-22 Warnings, Adverse reactions Exact identifier application applno (NDA): 018132 application number: NDA018132 DOPamine Hydrochloride DOPAMINE HYDROCHLORIDE Medical Purchasing Solutions, LLC b61fffd0-7bc8-09e2-e053-2995a90ae0e4 2023-05-30 Warnings, Adverse reactions Exact identifier application applno (NDA): 018132 application number: NDA018132
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51662-1220-1 51662122001 10 mL in 1 VIAL, SINGLE-DOSE (51662-1220-1) 10 ml 2018-08-23 0000-00-00 No No Current 51662-1220-2 51662122002 1 in 1 POUCH Historical 51662-1220-3 51662122003 25 POUCH in 1 CASE (51662-1220-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1220-2) / 10 mL in 1 VIAL, SINGLE-DOSE 25 pouch 2022-11-10 0000-00-00 No No Current